Literature DB >> 11782278

New insights regarding HLA-B27 diversity in the Asian population.

S García-Fernández1, S Gonzalez, A Miña Blanco, J Martinez-Borra, M Blanco-Gelaz, A López-Vazquez, C López-Larrea.   

Abstract

A polymerase chain reaction-sequence-specific primer (PCR-SSP) method which distinguishes all B27 alleles described at present (B*2701-23) has been developed. The distribution of B27 alleles was characterised in six different Asian populations. HLA-B*2705, 02, 04, 07, 22 (formerly B*2706) subtypes found in Asian populations differ in their ethnic distribution, which may be the result of different genetic and geographic origins. Furthermore, two novel B27 alleles were found in this study. B*2714 was identified in two Siberians, one of whom was a patient with ankylosing spondylitis. B*2715 was found in two patients with ankylosing spondylitis in Thais. These associations have not previously been reported in either ethnic group.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11782278     DOI: 10.1034/j.1399-0039.2001.580407.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  13 in total

Review 1.  Polymorphism of HLA-B27: 105 subtypes currently known.

Authors:  Muhammad Asim Khan
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

2.  Distribution of HLA-B27 and its alleles in patients with reactive arthritis and with ankylosing spondylitis in Tunisia.

Authors:  Mariam Siala; Nadia Mahfoudh; Radhouane Gdoura; Mohamed Younes; Hela Fourati; Arwa Kammoun; Ilhem Chour; Nihel Meddeb; Lilia Gaddour; Faiza Hakim; Sofien Baklouti; Naceur Bargaoui; Sleheddine Sellami; Adnene Hammami; Hafedh Makni
Journal:  Rheumatol Int       Date:  2009-01-20       Impact factor: 2.631

3.  The association of HLA-B*27 subtypes with ankylosing spondylitis in Wuhan population of China.

Authors:  Xiang Liu; Li-Hua Hu; Yi-Rong Li; Feng-Hua Chen; Yong Ning; Qun-Feng Yao
Journal:  Rheumatol Int       Date:  2009-06-18       Impact factor: 2.631

4.  Characterization of a proteasome and TAP-independent presentation of intracellular epitopes by HLA-B27 molecules.

Authors:  Adriana Magnacca; Irene Persiconi; Elisa Nurzia; Silvana Caristi; Francesca Meloni; Vincenzo Barnaba; Fabiana Paladini; Domenico Raimondo; Maria Teresa Fiorillo; Rosa Sorrentino
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

Review 5.  An Update on the Genetic Polymorphism of HLA-B*27 With 213 Alleles Encompassing 160 Subtypes (and Still Counting).

Authors:  Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

6.  No significant association between Fc receptor-like 3 gene polymorphisms and human leukocyte antigen-B27 positive ankylosing spondylitis in Han Chinese population.

Authors:  Guo Xia; Faming Pan; Fangfang Liao; Xiaowu Tang; Rui Ge; Yang Mei; Heping Pan; Shengqian Xu; Jianhua Xu
Journal:  Mol Biol Rep       Date:  2009-08-06       Impact factor: 2.316

7.  Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations.

Authors:  Carlos Lopez-Larrea; Miguel Angel Blanco-Gelaz; Juan Carlos Torre-Alonso; Jacome Bruges Armas; Beatriz Suarez-Alvarez; Laura Pruneda; Ana Rita Couto; Segundo Gonzalez; Antonio Lopez-Vázquez; Jesus Martinez-Borra
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

8.  Clinical Features in Juvenile-Onset Ankylosing Spondylitis Patients Carrying Different B27 Subtypes.

Authors:  Yikun Mou; Pingping Zhang; Qiuxia Li; Zhiming Lin; Zetao Liao; Qiujing Wei; Jieruo Gu
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

Review 9.  Progress in spondylarthritis. Progress in studies of the genetics of ankylosing spondylitis.

Authors:  Matthew A Brown
Journal:  Arthritis Res Ther       Date:  2009-10-29       Impact factor: 5.156

10.  Associations between HLA-B27 subtypes and outcomes in Thai children with enthesitis-related arthritis.

Authors:  Soamarat Vilaiyuk; Butsabong Lerkvaleekul; Duangtawan Thammanichanond
Journal:  Clin Rheumatol       Date:  2021-08-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.